Literature DB >> 3928553

Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.

Y Hosaka, M Muramatsu, T Matsushima, T Niijima, S Nagase.   

Abstract

The susceptibility of analbuminemic rats (Nagase analbuminemic rats; NAR) to induction of bladder cancer by oral N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) was studied. Male NAR and Sprague-Dawley rats (SD) were fed normal diet or normal diet supplemented with 0.2% FANFT for 10 weeks and killed in week 52. Bladder cancer was found in 5 of 24 SD (21%) but not in 18 NAR (0%). Proliferative lesions of the bladder epithelium, which are considered to be precancerous or more advanced than precancerous changes, were found in 16 of 24 SD (67%), but in only 4 of 18 NAR (22%). NAR showed lower susceptibility than control SD to induction of bladder cancer by FANFT.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928553

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  4 in total

Review 1.  Chemical carcinogenesis in analbuminemic rats.

Authors:  T Kakizoe; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1988-07

2.  Induction of intestinal adenocarcinomas by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Nagase analbuminemic rats.

Authors:  M Ochiai; K Ogawa; K Wakabayashi; T Sugimura; S Nagase; H Esumi; M Nagao
Journal:  Jpn J Cancer Res       Date:  1991-04

3.  Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of rat hepatocarcinogenesis in a medium-term assay system: quantitation of glutathione S-transferase P-positive foci development.

Authors:  M Asamoto; H Tsuda; M Kagawa; J L de Camargo; N Ito; S Nagase
Journal:  Jpn J Cancer Res       Date:  1989-10

4.  Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.

Authors:  J Nakanowatari; S Fukushima; K Imaida; N Ito; S Nagase
Journal:  Jpn J Cancer Res       Date:  1988-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.